Expert Reaction to OBSCORE: A New Tool for Obesity Risk Prediction
A study published in Nature Medicine introduces OBSCORE, a new tool designed to identify individuals at the highest risk of obesity-related complications to prioritize them for weight loss interventions. The Science Media Centre UK compiled expert reactions to this publication. Professor Naveed Sattar from the University of Glasgow described the study as a modest but well-executed contribution to existing literature. He noted that combining self-reported history with biomarkers and genetic data improves risk prediction, particularly for chronic kidney disease, though improvements for cardiovascular disease are limited compared to established scores. Sattar highlighted practical limitations, including the lack of routine access to certain variables within the NHS and the need for further validation before clinical implementation. He also suggested that as weight-loss treatments become more affordable and widespread, the reliance on such complex risk scores may diminish. Despite these caveats, the tool represents a step toward integrated risk prediction. The article includes declared interests for Professor Sattar, noting consultations with various pharmaceutical companies. This roundup provides a critical scientific perspective on the potential clinical utility and current limitations of the OBSCORE model.
Wire timeline
Expert Reaction to OBSCORE: A New Tool for Obesity Risk Prediction
A study published in Nature Medicine introduces OBSCORE, a new tool designed to identify individuals at the highest risk of obesity-related complications to prioritize them for weight loss interventions. The Science Media Centre UK compiled expert reactions to this publication. Professor Naveed Sattar from the University of Glasgow described the study as a modest but well-executed contribution to existing literature. He noted that combining self-reported history with biomarkers and genetic data improves risk prediction, particularly for chronic kidney disease, though improvements for cardiovascular disease are limited compared to established scores. Sattar highlighted practical limitations, including the lack of routine access to certain variables within the NHS and the need for further validation before clinical implementation. He also suggested that as weight-loss treatments become more affordable and widespread, the reliance on such complex risk scores may diminish. Despite these caveats, the tool represents a step toward integrated risk prediction. The article includes declared interests for Professor Sattar, noting consultations with various pharmaceutical companies. This roundup provides a critical scientific perspective on the potential clinical utility and current limitations of the OBSCORE model.
Science Media Centre